Clinical Trial

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-14; most recent amendment 2026-02-14.
Status change: Not Yet Recruiting → Recruiting 2026-02-14
Trial Details
NCT Number NCT07287943
Lead Sponsor Viral N. Shah
Collaborators: Medtronic
Conditions Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I
Enrollment 34 participants
Start Date 2026-02-09
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-18